Therapeutic intervention for Group C: standard-of-care Therapeutic intervention for Group R: standard-of-care and RE therapy
After eight weeks of therapy, the HbA1c level in Group R was statistically significantly lower than in Group C.
From these, adding RE therapy to the standard-of-care was inferred to be effective in improving glucose metabolism in patients with metabolic syndrome.
